You are here

anti-TNF

A pharma banking on the success of past blockbusters

Pharma Voice

Mon, 07/31/23 - 09:54 pm

180 Life Sciences

drug development

180 Life Sciences Poised to Break Ground with Anti-TNF Program

BioSpace

Sat, 01/16/21 - 11:42 pm

drug development

Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hint

Fierce Pharma

Wed, 07/8/20 - 11:58 pm

clinical trials

After painting a poor safety profile, Pfizer and Eli Lilly are shooting for a new pain drug OK anyway

Endpoints

Mon, 07/29/19 - 09:30 am

Protalix’ oral anti-TNF drug hits the mark in phase 2 ulcerative colitis trial

Fierce Biotech

Tue, 03/13/18 - 11:51 am

clinical trials

ulcerative colitis

As Johnson & Johnson holds off U.S. biosims, Remicade's European market share falls to 50%: report

Fierce Pharma

Tue, 12/5/17 - 06:31 pm

With Biogen launch, the U.K. has two anti-TNF biosims. In the U.S.? Not soon, analyst says

Fierce Pharma

Thu, 09/8/16 - 06:37 pm

Is the Anti-TNF Lead of AbbVie, Amgen, JNJ Nearing an End?

Bidness, ETC

Mon, 02/8/16 - 11:01 am

Biogen and Samsung's Enbrel biosimilar wins EMA nod for EU approval

Fierce Pharma

Fri, 11/20/15 - 06:21 pm

Biogen Goes Generic

Investopedia

Fri, 04/10/15 - 10:12 am

Abandonment rates indicate room in the anti-TNF market

Medical Marketing and Media

Fri, 01/16/15 - 08:52 am

Keep an Eye on Biogen, Johnson & Johnson, and Merck Today

Motley Fool

Tue, 12/17/13 - 10:42 am

Biogen Idec preps for a big leap into the anti-TNF blockbuster biosimilars market

Fierce Biotech

Tue, 12/17/13 - 09:39 am

Samsung Bioepis